In a meta-analysis focusing on serum diagnostic biomarkers for NPC, the sensitivities of VCA-IgA, Rta-IgG, and EA-IgA were reported as 0.85, 0.70, and 0.55, respectively 32. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.